A prospective randomized controlled clinical study on remote blood pressure monitoring combined with remote fetal monitoring and outpatient monitoring in patients with preeclampsia
Phase 1
Recruiting
- Conditions
- Maternal-Fetal Medicine
- Registration Number
- ChiCTR2400088945
- Lead Sponsor
- Shenzhen Second People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Analyze and evaluate the effectiveness and safety of remote blood pressure monitoring combined with remote fetal monitoring for monitoring preeclampsia patients during pregnancy, and determine whether this technology can replace and outperform the traditional management method of outpatient monitoring for preeclampsia patients.<br><br>2. Research and develop corresponding regulatory standards to improve pregnancy outcomes while minimizing hospital admissions, saving time and costs, and providing patient convenience, in order to ensure the safety of mother and fetus for preeclampsia patients.<br><br>1. Adult pregnant and postpartum women (= 18 years old); If the gestational age is = 30 weeks and = 36 weeks, the informed consent form of the patient shall be signed.<br><br>2. Diagnostic criteria: After 20 weeks of pregnancy, blood pressure increases, systolic blood pressure is greater than or equal to 140mm Hg, and/or diastolic blood pressure is greater than or equal to 90mm Hg, accompanied by 24-hour urine protein quantification greater than 0.3g or random urine protein (+) or combined with thrombocytopenia, liver function damage, renal function damage, pulmonary edema, newly occurring central nervous system abnormalities or visual impairment.<br>3. Single or twin pregnancy.
Exclusion Criteria
- Severe preeclampsia <br>2) Diagnosed with cardiovascular and cerebrovascular diseases before pregnancy<br>3) Individuals with mental illness <br>4) have communication barriers<br>5) Patients with severe metabolic diseases <br>6) Patients with immune diseases<br>7) Patients with concomitant coagulation dysfunction <br>8) Patients with incomplete clinical data<br>9) Those with poor compliance
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse outcomes in newborns;
- Secondary Outcome Measures
Name Time Method Maternal complications;